Aspirin and Dipyridamole Extended Release
- Product NDC
- 47335-927
- 11-digit product format
- 473350927
- Labeler code
- 47335
- Product ID
- 47335-927_5a1d740e-6d21-4756-b521-365b6cfd6cf6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Aspirin and Dipyridamole Extended Release
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA208572
- Marketing category
- ANDA
- Marketing start
- 2018-12-01
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN; DIPYRIDAMOLE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| R16CO5Y76E | ASPIRIN | 50-78-2 | ASPIRIN |
| 64ALC7F90C | DIPYRIDAMOLE | 58-32-2 | DIPYRIDAMOLE |